Amylyx Pharmaceuticals (NASDAQ:AMLX) reported quarterly losses of $(0.65) per share which beat the analyst consensus estimate of $(0.82) by 20.73 percent. The company reported quarterly sales of $21.89 million which beat the analyst consensus estimate of $4.72 million by 363.67 percent.
Century Aluminum Issues Statement Of Support For New Biden Administration Tariffs On Russian Aluminum
Century Aluminum Company (NASDAQ:CENX) today released the following statement from President and Chief Executive Officer Jesse Gary in support of the Biden administration's decision to implement
